Natera Co-Founder Sells $800K in NTRA Stock via 10b5-1 Plan
Natera, Inc.
Subscribe to track NTRA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Natera Co-Founder Sells $800K in NTRA Stock via 10b5-1 Plan
Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2025-11-04 Significance: Low
Insider: Sheena Jonathan Title: null | Relationship: Director, Co-Founder
Transaction: • Type: Sale • Shares: 4,000 • Price: $200.07 • Value: $800,274 • Owned After: 287,794
Key Insight: A Co-Founder sold a small portion (~1.4%) of their total holdings via a pre-scheduled 10b5-1 trading plan. The transaction value is insignificant relative to Natera's $27.21B market cap.
Market Context: This sale was executed under a trading plan adopted in June 2024, indicating it was planned far in advance and is likely for personal financial management rather than a reaction to current company performance.
Comprehensive Analysis
SEC Filing Analysis: Natera, Inc. (NTRA)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A Co-Founder conducted a minor, pre-planned sale of common stock, representing a negligible fraction of the company's market capitalization and the insider's total holdings.
- Market Impact: The transaction is too small to have a meaningful impact on the stock's price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | Natera, Inc. |
| Ticker Symbol | NTRA |
| CIK | 0001604821 |
| Industry | SERVICES-MEDICAL LABORATORIES |
Insider Information
| Field | Value |
|---|---|
| Name | Sheena Jonathan |
| CIK | 0001646649 |
| Title/Position | null |
| Relationship | Director, Co-Founder |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 4,000 |
| Price Per Share | $200.07 (Weighted Avg) |
| Total Value | $800,273.60 |
| Shares Owned After | 287,794 (Direct & Indirect) |
| Ownership Type | Indirect |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $800,273.60 |
| % of Market Cap | 0.003% |
| Shares Transacted | 4,000 |
| % of Shares Outstanding | 0.003% |
| Post-Transaction Ownership | 287,794 shares (0.21% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $800k sale is trivial for a large-cap company with a market capitalization of $27.21 billion.
- Ownership Concentration: The insider's post-transaction ownership of 0.21% is not a controlling stake. The sale of 4,000 shares, representing just 1.37% of the insider's prior holdings, does not materially change their position.
- Transaction Significance: Based on the transaction's value being less than 0.1% of market cap and shares transacted being less than 0.1% of shares outstanding, the event is considered routine and of low significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is immaterial in size relative to the company's market cap and daily trading volume. Furthermore, it was executed under a Rule 10b5-1 plan, which negates the signal of immediate insider sentiment.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is unlikely to be noticeable against the stock's typical daily volume.
- Sentiment Indicator: Neutral. Pre-planned sales by long-term insiders for portfolio diversification or personal liquidity are common and do not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The sales were executed pursuant to a Rule 10b5-1 trading plan adopted on June 7, 2024. This indicates the transactions were pre-scheduled for asset diversification or liquidity purposes and not based on any immediate, non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
